Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
European Journal of Clinical Investigation
|
April 2, 2009
Endothelin receptor antagonists in preclinical models of pulmonary hypertension
S S Pullamsetti, R T Schermuly
Deutsche Medizinische Wochenschrift (1946)
|
September 1, 2009
[Update: Preclinical developments for the treatment of pulmonary arterial hypertension]
W Janssen, H A Ghofrani, N Weissmann, et al.
European Journal of Clinical Investigation
|
April 2, 2009
The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies
N J Davie, R T Schermuly, N Weissmann, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 5, 2000
Differential impact of ultrasonically nebulized versus tracheal-instilled surfactant on ventilation-perfusion (VA/Q) mismatch in a model of acute lung injury
R T Schermuly, A Günther, N Weissmann, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
April 6, 2001
Alveolar epithelial barrier functions in ventilated perfused rabbit lungs
H A Ghofrani, M G Kohstall, N Weissmann, et al.
American Journal of Respiratory Cell and Molecular Biology
|
August 2, 2000
Nitric oxide (NO)-dependent but not NO-independent guanylate cyclase activation attenuates hypoxic vasoconstriction in rabbit lungs
N Weissmann, R Voswinckel, A Tadic, et al.
Zeitschrift Fur Kardiologie
|
August 10, 2000
[Inhalative strategies for improvement of pulmonary hemodynamics and gas exchange in sepsis and severe pulmonary hypertension]
F Grimminger, F Rose, H A Ghofrani, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 11, 1999
Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension
R T Schermuly, H A Ghofrani, B Enke, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 13, 2001
Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension
R T Schermuly, A Roehl, N Weissmann, et al.
American Journal of Respiratory Cell and Molecular Biology
|
August 18, 2001
Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication
R T Schermuly, N Weissmann, B Enke, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
European Journal of Clinical Investigation
|
April 2, 2009
Endothelin receptor antagonists in preclinical models of pulmonary hypertension
S S Pullamsetti, R T Schermuly
Deutsche Medizinische Wochenschrift (1946)
|
September 1, 2009
[Update: Preclinical developments for the treatment of pulmonary arterial hypertension]
W Janssen, H A Ghofrani, N Weissmann, et al.
European Journal of Clinical Investigation
|
April 2, 2009
The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies
N J Davie, R T Schermuly, N Weissmann, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 5, 2000
Differential impact of ultrasonically nebulized versus tracheal-instilled surfactant on ventilation-perfusion (VA/Q) mismatch in a model of acute lung injury
R T Schermuly, A Günther, N Weissmann, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
April 6, 2001
Alveolar epithelial barrier functions in ventilated perfused rabbit lungs
H A Ghofrani, M G Kohstall, N Weissmann, et al.
American Journal of Respiratory Cell and Molecular Biology
|
August 2, 2000
Nitric oxide (NO)-dependent but not NO-independent guanylate cyclase activation attenuates hypoxic vasoconstriction in rabbit lungs
N Weissmann, R Voswinckel, A Tadic, et al.
Zeitschrift Fur Kardiologie
|
August 10, 2000
[Inhalative strategies for improvement of pulmonary hemodynamics and gas exchange in sepsis and severe pulmonary hypertension]
F Grimminger, F Rose, H A Ghofrani, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 11, 1999
Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension
R T Schermuly, H A Ghofrani, B Enke, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 13, 2001
Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension
R T Schermuly, A Roehl, N Weissmann, et al.
American Journal of Respiratory Cell and Molecular Biology
|
August 18, 2001
Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication
R T Schermuly, N Weissmann, B Enke, et al.
Page
of 4